OBiS Insights pre-meeting ESMO24 report is based on a review of the 2,960 abstract titles of which 275 new not yet approved drugs have been profiled. NEW YORK, NY, UNITED STATES, September 12, 2024 ...
Some results have been hidden because they may be inaccessible to you